Media Coverage of BIO’s Intellectual Property Conference in Seattle | Patently BIOtech

Email Subscription

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 15 other followers
Recent Posts
Categories
Top Clicks
- None
brought to you by
Biotechnology Industry Organization
1201 Maryland Ave., SW
Washington, DC 20024
202.962.9200
www.bio.org

terms of use
privacy policy

Media Coverage of BIO’s Intellectual Property Conference in Seattle

Posted on April 20, 2011 by rzwahlen

Stanford v. Roche: An Academic/Industry Collaboration Gone Wrong

A Landmark Case: The Aftermath of Myriad Genetics

Ethical Issues: Staying in the Frying Pan and out of the Fire

Advertisements

Related

Filed under: IP Counsels' Committee, Uncategorized | Tagged: Academic and industry collaboration, AMP v. USPTO, Gene Quinn, IP Ethics, IP Watchdog, Myriad, Stanford v. Roche |

« House Judiciary Committee’s Patent Reform Bill is in Need of Reform, Says BIO Scientists oppose European stem cell patent ban »

One Response

patent litigation, on April 26, 2011 at 12:13 am said:

The next time patent reform comes before Congress, our legislators should do more to solicit the input of independent innovators and other SMEs.

Reply

Leave a Reply Cancel reply

Enter your comment here...

Fill in your details below or click an icon to log in:

Email (required) (Address never made public)

Name (required)

Website

You are commenting using your WordPress.com account. ( Log Out / Change )

You are commenting using your Twitter account. ( Log Out / Change )

You are commenting using your Facebook account. ( Log Out / Change )

You are commenting using your Google+ account. ( Log Out / Change )

Connecting to %s

%d bloggers like this: